PDLIM1 and type 1 diabetes mellitus: This included SPINK9, TRDN, PVRL4, MYO3A, PDLIM1, KIAA1614 and GRP. The findings of the present study support the potentiality of SPINK9 and MYO3A as candidate biomarkers for development of T1DM complications.